Work

GLP-1 Receptor Agonists and Obesity-Related Cancer by Diabetes Severity

Year: 2026

Type: article

Abstract: This cohort study examines the associations between glucagon-like peptide-1 receptor agonist (GLP-1 RA) initiation and obesity-related cancer incidence across active comparators and baseline type 2 diabetes severity.

Source: JAMA Network Open

DOI: 10.1001/jamanetworkopen.2026.41869

Authors: Jesús Gibran Hernández-Pérez, Omer Abdelgadir, Luisa Torres-Sánchez, Jing Chen, Jaime P. Almandoz, Lindsay G. Cowell, Sarah E. Messiah, David S. Lopez

Institutions: Instituto Nacional de Salud Pública, The University of Texas Southwestern Medical Center, Harold C. Simmons Comprehensive Cancer Center

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,000

Funders: National Institutes of Health, National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases, National Center for Advancing Translational Sciences

OpenAlex ID: W7225147117

FWCI:

Cites: 9

Cited by:

Related to: 10